23 Dec 2021 Peter Scheyltjens (52), CEO en oprichter van de Advipro Groep, geeft de fakkel door aan zijn rechterhand Toon Witvrouwen (35) Member news
20 Dec 2021 Biotalys and Biobest enter into strategic partnership to expand reach of novel biocontrol solutions Member news
20 Dec 2021 argenx announces U.S. Food and Drug Administration (FDA) approval of VYVGART™ (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis Member news
10 Dec 2021 UCB announces positive Phase 3 results for rozanolixizumab in generalized myasthenia gravis Member news
08 Dec 2021 MRM Health announces first patient dosed with next generation live microbiome consortia therapeutic MH002 in Phase 1b/2a study in patients with Ulcerative Colitis Member news
07 Dec 2021 Sequana Medical announces the completion of patient enrolment in POSEIDON, the North American pivotal alfapump® study Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
